Emotional manifestations of PD: Neurobiological basis. Issue 8 (4th April 2016)

• Record Type: Journal Article
• Authors: Castrioto, Anna; Thobois, Stéphane; Carnicella, Sebastien; Maillet, Audrey; Krack, Paul
• Is Part Of: Movement disorders. Volume 31:Issue 8(2016)
• Page Start: 1103
• Page End: 1113
• Publication Date: 2016-04-04
• Subjects: Parkinson's disease -- dopamine -- apathy -- depression -- anxiety; Movement disorders -- Periodicals; 610
• DOI: 10.1002/mds.26587
• Languages: English
• ISSNs: 0885-3185

Abstract

ABSTRACT: Neuropsychiatric symptoms are common and disabling in PD. Their neurobiological bases are complex, partly because of the disease itself and partly because of the dopaminergic treatment. The aim of this review is to focus on the emotional manifestations stemming from the neurodegenerative process itself. We focus on depression, anxiety, apathy, and fatigue, which can all be part of the clinical spectrum of premotor disease and may be improved or masked by medications targeting parkinsonian motor signs or psychiatric symptoms as the disease progresses. Findings from clinical, neuroimaging, and animal studies are reviewed, showing a major contribution of the dopaminergic system to the pathophysiology of these disabling symptoms. Degeneration of noradrenergic and serotonergic projection systems also has an impact on psychiatric symptoms of PD. The available literature is reviewed, but at present there is a lack of studies that would allow disentangling the separate contribution of each of the monoaminergic systems. The use of a pragmatic classification of all these symptoms under the umbrella of hypodopaminergic behavioral syndrome seems clinically useful, as it emphasizes the crucial, although not exclusive, nature of their dopaminergic neurobiological basis, which has important implications in the clinical management of PD. © 2016 International Parkinson and Movement Disorder Society